1Rossi GP, Bernini G, Caliumi C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients [J]. J Am Coil Cardiol, 2006,48 ( 11 ) : 2293-2300. DOI : 10. lO16/j, jacc. 2006.07. 059.
2Calhoun DA, Nisbizaka MK, Zaman MA, et al. Hyperaldosteronism among black and white subjects with resistant hypertension [ J ]. Hypertension, 2002,40(6) :892-896.
3Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline [ J ]. J Clin Endocrinol Metab, 2008,93 ( 9 ) : 3266-3281. DOI: 10. 1210/jc. 2008-0104.
4Sang X, Jiang Y, Wang W, et al. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China [J]. J Hypertens, 2013,31 (7) : 1465-1471 ; discussion 1471-1472. DOI: 10. 1097/HJH. ObO13e328360ddf6.
5Fallo F, Veglio F, Bertello C, et al. Prevalence and eharaeteristics of the metabolic syndrome in primary aldosteronism [ J ]. J Clin Endocrinol Metal), 2006,91 (2) :454-459. DOI: 10. 1210/jc. 2005-1733.
6Milliez P, Girerd X, Plouin PF, et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism [ J ]. J Am Coil Cardiol, 2005,45 ( 8 ) : 1243-1248. DOI : 10. 1016/j. jacc. 2005. 01.015.
8Rios MC, Izquierdo A, Solelo M, et al. Aldosterone/renin ratio in the diagnosis of primary. ',ddosteronism [ J ]. Medicina ( B Aires ) , 2011,71 (6) :525-530.
9Rossi G, Boscaro M, Ronconi V, et al. Aldosterone as a cardiovascular risk factor[ J ]Trends Endocrinol Metab, 2005,16 ( 3 ) : 104-107. DOI : 10. 1016/j. tent. 2005.02. 010.
10Reincke M, Rump LC, Quinkler M, et al. Risk factors associated with a low glomerular filtration rate inprimary aldosteronism [ J ]. J Clin Endocrinnl Metab, 2009,94 (3) :869-875. DOI: 10. 1210/je. 2008- 1851.
